These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 31069370)

  • 1. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal relationships, antimicrobial susceptibilities, and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolates from urinary tract infections and fecal samples in Southeast Iran.
    Hashemizadeh Z; Kalantar-Neyestanaki D; Mansouri S
    Rev Soc Bras Med Trop; 2018; 51(1):44-51. PubMed ID: 29513841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
    Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
    J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase-producing
    Romyasamit C; Sornsenee P; Kawila S; Saengsuwan P
    Microbiol Spectr; 2024 Jul; 12(7):e0021324. PubMed ID: 38809095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of ESBLs among Escherichia coli isolates from outpatients with recurrent UTIs and their antimicrobial resistance.
    Al-Mayahie S; Al Kuriashy JJ
    J Infect Dev Ctries; 2016 Jun; 10(6):575-83. PubMed ID: 27367005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of Extended-spectrum β lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt.
    Hassuna NA; Khairalla AS; Farahat EM; Hammad AM; Abdel-Fattah M
    Sci Rep; 2020 Feb; 10(1):2772. PubMed ID: 32066805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela.
    Guzmán M; Salazar E; Cordero V; Castro A; Villanueva A; Rodulfo H; De Donato M
    Biomedica; 2019 May; 39(s1):96-107. PubMed ID: 31529852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections.
    Tayebi Z; Heidari H; Kazemian H; Ghafoori SM; Boroumandi S; Houri H
    Infez Med; 2016 Dec; 24(4):326-330. PubMed ID: 28011969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of NDM metallo-β-lactamase among ESBL-producing Escherichia coli İsolates.
    Çetinkol Y; Sandalli C; Çalgin MK; Yildirim AA; Akyildiz E; Karaman E; Çiçek AÇ
    Acta Microbiol Immunol Hung; 2017 Jun; 64(2):131-141. PubMed ID: 28420242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
    Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
    Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients.
    Brigante G; Luzzaro F; Perilli M; Lombardi G; Colì A; Rossolini GM; Amicosante G; Toniolo A
    Int J Antimicrob Agents; 2005 Feb; 25(2):157-62. PubMed ID: 15664486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance dissemination by extended-spectrum β-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil.
    Gonçalves LF; de Oliveira Martins-Júnior P; de Melo ABF; da Silva RCRM; de Paulo Martins V; Pitondo-Silva A; de Campos TA
    J Glob Antimicrob Resist; 2016 Sep; 6():1-4. PubMed ID: 27530830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of the Colistin Resistance Gene
    Mikhayel M; Leclercq SO; Sarkis DK; Doublet B
    Microbiol Spectr; 2021 Oct; 9(2):e0002521. PubMed ID: 34494875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characterization and molecular epidemiology of ESBL in Escherichia coli and Klebsiella pneumoniae in 11 Spanish hospitals (2004)].
    Diestra K; Coque TM; Miró E; Oteo J; Nicolau CJ; Campos J; Moyá B; Curiao T; Pérez-Vázquez M; Cantón R; Oliver A; Navarro F;
    Enferm Infecc Microbiol Clin; 2008; 26(7):404-10. PubMed ID: 18842234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of extended-spectrum β-lactamase (ESBL) and plasmid-borne bla
    Haghighatpanah M; Mozaffari Nejad AS; Mojtahedi A; Amirmozafari N; Zeighami H
    J Glob Antimicrob Resist; 2016 Dec; 7():110-113. PubMed ID: 27721192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.